{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T05:08:28Z","timestamp":1788671308893,"version":"build-2803163510"},"reference-count":41,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2012]]},"DOI":"10.2169\/internalmedicine.51.7686","type":"journal-article","created":{"date-parts":[[2012,6,30]],"date-time":"2012-06-30T22:43:04Z","timestamp":1341096184000},"page":"1683-1688","source":"Crossref","is-referenced-by-count":25,"title":["Incidence and the Risk Factor of Malignancy in Japanese Patients with Systemic Sclerosis"],"prefix":"10.2169","volume":"51","author":[{"given":"Atsushi","family":"Hashimoto","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan"},{"name":"Department of Rheumatology, Sagamihara National Hospital, National Hospital Organization, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Arinuma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Sagamihara National Hospital, National Hospital Organization, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Nagai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiaki","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Sagamihara National Hospital, National Hospital Organization, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, National Hospital Organization, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirahito","family":"Endo","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsei","family":"Hirohata","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.066068"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hashimoto A, Tejima S, Tono T, et al. Predictors of survival and causes of death in Japanese patients with systemic sclerosis. J Rheumatol 38: 1931-1939, 2011.","DOI":"10.3899\/jrheum.100298"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Barnett AJ, Coventry DA. Scleroderma. 1. Clinical features, course of illness and response to treatment in 61 cases. Med J Aust 1: 992-1001, 1969.","DOI":"10.5694\/j.1326-5377.1969.tb49844.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hashimoto A, Endo H, Kondo H, Hirohata S. Clinical features of 405 Japanese patients with systemic sclerosis. Mod Rheumatol 2011 [Epub ahead of print].","DOI":"10.1007\/s10165-011-0515-7"},{"key":"5","unstructured":"6. Barnett AJ, Miller MH, Littlejohn GO. A survival study of patients with scleroderma diagnosed over 30 years (1953-1983): the value of a simple cutaneous classification in the early stages of the disease. J Rheumatol 15: 276-283, 1988."},{"key":"6","unstructured":"7. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15: 202-205, 1988."},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(05)70021-2"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(84)90986-0"},{"key":"9","unstructured":"10. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 67: 2089-2100, 2005."},{"key":"10","unstructured":"11. Hatano S, Strasser T. Primary Pulmonary Hypertension: Report on a WHO Meeting, Geneva 15-17 October 1973. World Health Organization, Geneva, 1975."},{"key":"11","doi-asserted-by":"crossref","unstructured":"12. Schachna L, Wigley FM, Chang B, White B, Wise RA, Gelber AC. Age and risk of pulmonary arterial hypertension in scleroderma. Chest 124: 2098-2104, 2003.","DOI":"10.1378\/chest.124.6.2098"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780251101"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-004-0338-x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"16. Cancer incidence in Japan, 1985-89: re-estimation based on data from eight population-based cancer registries. The Research Group for Population-based Cancer Registration in Japan. Jpn J Clin Oncol 28: 54-67, 1998.","DOI":"10.1093\/jjco\/28.1.54"},{"key":"16","unstructured":"17. Ajiki W, Tsukuma H, Oshima A, Research Group for Population-based Cancer Registration in Japan. Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol 34: 352-356, 2004."},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90376-7"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.115.8.950"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780250916"},{"key":"20","unstructured":"21. Chatterjee S, Dombi GW, Severson RK, Mayes MD. Risk of malignancy in scleroderma: a population-based cohort study. Arthritis Rheum 52: 2415-2424, 2005."},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780281204"},{"key":"22","unstructured":"23. Rosenthal AK, McLaughlin JK, Linet MS, Persson I. Scleroderma and malignancy: an epidemiological study. Ann Rheum Dis 52: 531-533, 1993."},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360405"},{"key":"24","doi-asserted-by":"crossref","unstructured":"25. Rosenthal AK, McLaughlin JK, Gridley G, Nyr&eacute;n O. Incidence of cancer among patients with systemic sclerosis. Cancer 76: 910-914, 1995.","DOI":"10.1002\/1097-0142(19950901)76:5<910::AID-CNCR2820760528>3.0.CO;2-T"},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1007\/s100670050029"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.8.728"},{"key":"27","unstructured":"28. Derk CT, Rasheed M, Artlett CM, Jimenez SA. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 33: 1113-1116, 2006."},{"key":"28","unstructured":"29. Kang KY, Yim HW, Kim IJ, et al. Incidence of cancer among patients with systemic sclerosis in Korea: results from a single centre. Scand J Rheumatol 38: 299-303, 2009."},{"key":"29","unstructured":"31. Fuse Y, Masuyama J, Yoshio T, et al. Progressive systemic sclerosis (PSS) and cancer: increasing coincidence rate of cancer in 67 PSS patients. Ryumachi 35: 25-31, 1995 (in Japanese, abstract in English)."},{"key":"30","doi-asserted-by":"crossref","unstructured":"32. Nishioka K, Katayama I, Kondo H, et al. Epidemiological analysis of prognosis of 496 Japanese patients with progressive systemic sclerosis (SSc). Scleroderma Research Committee Japan. J Dermatol 23: 677-682, 1996.","DOI":"10.1111\/j.1346-8138.1996.tb02680.x"},{"key":"31","unstructured":"33. Peters-Golden M, Wise RA, Hochberg M, Stevens MB, Wigley FM. Incidence of lung cancer in systemic sclerosis. J Rheumatol 12: 1136-1139, 1985."},{"key":"32","unstructured":"34. Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T. Lung cancer associated with several connective tissue diseases: with a review of literature. Rheumatol Int 1: 106-111, 2001."},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1136\/thx.35.7.496"},{"key":"34","doi-asserted-by":"crossref","unstructured":"36. Matsushita H, Tanaka S, Saiki Y, et al. Lung cancer associated with usual interstitial pneumonia. Pathol Int 45: 925-932, 1995.","DOI":"10.1111\/j.1440-1827.1995.tb03417.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"37. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 161: 5-8, 2000.","DOI":"10.1164\/ajrccm.161.1.9906062"},{"key":"36","doi-asserted-by":"crossref","unstructured":"38. Samet JM. Does idiopathic pulmonary fibrosis increase lung cancer risk? Am J Respir Crit Care Med 161: 1-2, 2000.","DOI":"10.1164\/ajrccm.161.1.ed14-99"},{"key":"37","doi-asserted-by":"crossref","unstructured":"39. Raghu G, Nyberg F, Morgan G. The epidemiology of interstitial lung disease and its association with lung cancer. Br J Cancer 91 (Suppl 2): S3-S10, 2004.","DOI":"10.1038\/sj.bjc.6602061"},{"key":"38","doi-asserted-by":"crossref","unstructured":"40. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 11: 431-437, 2005.","DOI":"10.1097\/01.mcp.0000170521.71497.ba"},{"key":"39","unstructured":"42. Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 165: 2337-2344, 2005."},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350621"},{"key":"41","unstructured":"44. Pontifex EK, Hill CL, Roberts-Thomson P. Risk factors for lung cancer in patients with scleroderma: a nested case-control study. Ann Rheum Dis 66: 551-553, 2007."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/13\/51_51.7686\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T17:44:37Z","timestamp":1621446277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/51\/13\/51_51.7686\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":41,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.51.7686","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}